Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 17 February 2023
Sec. Cancer Imaging and Image-directed Interventions
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1095362

RETRACTED: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis

Retracted

A retraction of this article was approved in:

  1. Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis

    1. Read retraction
Fangcheng Shen&#x;Fangcheng Shen†Jing Li&#x;Jing Li†Feng LiuFeng LiuNi SunNi SunXiangNan QiuXiangNan QiuWei Ding*&#x;Wei Ding*‡XiangDong Sun*&#x;XiangDong Sun*‡
  • Radiotherapy Department, Nanjing JinLing Hospital, Xuanwu District, Nanjing, Jiangsu, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Shen F, Li J, Liu F, Sun N, Qiu X, Ding W and Sun X (2023) The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis. Front. Oncol. 13:1095362. doi: 10.3389/fonc.2023.1095362

Received: 11 November 2022; Accepted: 19 January 2023;
Published: 17 February 2023; Retracted: 20 February 2024.

Edited by:

Min Tang, Jiangsu University, China

Reviewed by:

Chen Li, Free University of Berlin, Germany
Jichang Han, Washington University in St. Louis, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.